[Adverse effects of branched chain amino acid transfusion on type-II citrullinemia--report of an adult case].
A 24-year-old man was admitted to our hospital, because two days before the admission he had abruptly lost consciousness following generalized convulsive seizures. He had a past history of transient amnesia and a favor for peanuts. His grandparents had a record of consanguinity. On admission, he was comatose and flaccid with his four extremities. Laboratory examination revealed the followings; mild degree of abnormal liver function, slight elevation of blood ammonia, irregular theta basic rhythm on EEG, marked brain edema on CT and a normal liver ultrasonography. From the second hospital day, in addition to antiepileptic drugs and adrenocorticosteroids, branched chain amino acid was administered to reactivate damaged brain functions. Thereafter, the concentration of blood ammonia increased to more than 3,000 micrograms/dl, and as a result he fell into status epilepticus. On the fourth hospital day, the levels of citrulline in the plasma and urine taken on the first hospital day were found to have increased by 20 and 100 times, respectively. Although the transfusion of branched chain amino acid was stopped, he died while in coma on the 12th hospital day. Enzymatic analyses of necropsied liver specimens revealed that the quantitative activity of argininosuccinate synthetase had decreased to less than 10% in his urea cycle. In this patient, it was noted that, after transfusion of branched chain amino acid, his brain activities turned worse and blood ammonia was markedly elevated. There is a possibility that intravenous administration of branched chain amino acid may interrupt the urea cycle balance in an adult patient of citrullinemia with dysfunction of the brain, kidney and muscle, especially with brain edema.(ABSTRACT TRUNCATED AT 250 WORDS)
Shindo
K
K
Third Department of Internal Medicine, Yamanashi Medical University.
Tsunoda
S
S
Shiozawa
Z
Z
D000328:Adult; D000592:Amino Acid Metabolism, Inborn Errors / Q000188:drug therapy* / Q000378:metabolism; D000597:Amino Acids, Branched-Chain / Q000008:administration & dosage / Q000009:adverse effects*; D000641:Ammonia / Q000097:blood* / Q000134:cerebrospinal fluid; D001124:Argininosuccinate Synthase / Q000378:metabolism; D002956:Citrulline / Q000097:blood*; D006801:Humans; D007262:Infusions, Intravenous; D008099:Liver / Q000201:enzymology; D008297:Male; D014508:Urea / Q000378:metabolism
D000597:Amino Acids, Branched-Chain; D002956:Citrulline; D000641:Ammonia; D014508:Urea; D001124:Argininosuccinate Synthase